A comparison study of Lipid and Polymeric Nanoparticles in the Nasal Delivery of Meloxicam: Formulation, Characterization, and In-Vitro Evaluation.

Two types of nanocarriers are developed, poly (lactic-co-glycolic acid) nanoparticles and solid lipid nanoparticles (SLNs), for the IN delivery of MEL adapting the Quality by Design approach (QbD), to further enhance the optimized nanoformulation behavior by chitosan-coating.